Researchers review the role of integrins in human hepatocellular carcinoma

by Cactus CommunicationsIn a recent review article, researchers summarize the roles integrins play in cancer cells and the current status of anti-integrin therapy for cancer. As a family of unique tra

Updated on: January 30,2024 13

Researchers review the role of integrins in human hepatocellular carcinoma

by Cactus CommunicationsIn a recent review article, researchers summarize the roles integrins play in cancer cells and the current status of anti-integrin therapy for cancer. As a family of unique tra

Updated on:January 30,2024 13

Researchers discover a weakness in a rare cancer that could be exploited with drugs

by Rockefeller UniversitySome cancer cells cannot produce cholesterol, and instead build up an excess of squalene (pink)--a molecule that may help these dangerous cells thrive. Credit: Laboratory

Updated on: June 19,2024 5

Researchers discover a weakness in a rare cancer that could be exploited with drugs

by Rockefeller UniversitySome cancer cells cannot produce cholesterol, and instead build up an excess of squalene (pink)--a molecule that may help these dangerous cells thrive. Credit: Laboratory

Updated on:June 19,2024 5

Boosting anti-cancer antibodies by reducing their grip

byUniversity of SouthamptonIllustration of antibodies binding receptors and stimulating them. Credit: University of SouthamptonNew research from the Centre for Cancer Immunology at the Universit

Updated on: January 07,2024 9

Boosting anti-cancer antibodies by reducing their grip

byUniversity of SouthamptonIllustration of antibodies binding receptors and stimulating them. Credit: University of SouthamptonNew research from the Centre for Cancer Immunology at the Universit

Updated on:January 07,2024 9

Immune cells assemble to boost the effects of chemotherapy in pancreatic cancer

by Queen Mary, University of LondonAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA new study from Queen Mary University of London has

Updated on: May 28,2024 7

Immune cells assemble to boost the effects of chemotherapy in pancreatic cancer

by Queen Mary, University of LondonAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA new study from Queen Mary University of London has

Updated on:May 28,2024 7

'Bad fat' suppresses killer T cells from attacking cancer

by Salk InstituteCredit: CC0 Public DomainIn order for cancer to grow and spread, it has to evade detection by our immune cells, particularly specialized "killer" T cells. Salk research

Updated on: March 13,2024 18

'Bad fat' suppresses killer T cells from attacking cancer

by Salk InstituteCredit: CC0 Public DomainIn order for cancer to grow and spread, it has to evade detection by our immune cells, particularly specialized "killer" T cells. Salk research

Updated on:March 13,2024 18

Two-stage transplantation is a viable treatment option for liver metastases, shows study

by Uta von der Gönna, Universitätsklinikum JenaSurgical procedure: At first, only a lobe of the liver with metastases (1) is removed (2) and replaced with a healthy partial organ. Reduced blood flow t

Updated on: January 16,2024 19

Two-stage transplantation is a viable treatment option for liver metastases, shows study

by Uta von der Gönna, Universitätsklinikum JenaSurgical procedure: At first, only a lobe of the liver with metastases (1) is removed (2) and replaced with a healthy partial organ. Reduced blood flow t

Updated on:January 16,2024 19

Study finds 5-year relative survival rate of 59.6 percent in lower-risk myelodysplastic syndromes

by Elana Gotkine HealthDay ReporterAbout 40 percent of patients with lower-risk myelodysplastic syndromes (LR-MDS) die of MDS within five years, according to a study published online Nov. 6 in the&nbs

Updated on: January 23,2024 14

Study finds 5-year relative survival rate of 59.6 percent in lower-risk myelodysplastic syndromes

by Elana Gotkine HealthDay ReporterAbout 40 percent of patients with lower-risk myelodysplastic syndromes (LR-MDS) die of MDS within five years, according to a study published online Nov. 6 in the&nbs

Updated on:January 23,2024 14

French Polynesia nuke tests slightly increased cancer risk: Study

Underground nuclear tests in French Polynesia in 1985 have been a source of friction between Paris and the archipelago.Polynesians exposed to fallout from France's nuclear tests in the South Pacif

Updated on: February 20,2024 13

French Polynesia nuke tests slightly increased cancer risk: Study

Underground nuclear tests in French Polynesia in 1985 have been a source of friction between Paris and the archipelago.Polynesians exposed to fallout from France's nuclear tests in the South Pacif

Updated on:February 20,2024 13

Small molecule drug reverses ADAR1-induced cancer stem cell cloning capacity

byUniversity of California - San DiegoA colorized scanning electron micrograph depicts human red blood cells. Credit: UC San Diego Health SciencesResearchers at University of California San Dieg

Updated on: January 11,2024 8

Small molecule drug reverses ADAR1-induced cancer stem cell cloning capacity

byUniversity of California - San DiegoA colorized scanning electron micrograph depicts human red blood cells. Credit: UC San Diego Health SciencesResearchers at University of California San Dieg

Updated on:January 11,2024 8

New model shows potential for human papillomavirus vaccination switch to 1-dose gender-neutral approach

byCanadian Medical Association JournalCredit: Unsplash/CC0 Public DomainCanadian vaccination programs could switch to a 1-dose gender-neutral human papillomavirus (HPV) vaccination approach and

Updated on: November 11,2024 0

New model shows potential for human papillomavirus vaccination switch to 1-dose gender-neutral approach

byCanadian Medical Association JournalCredit: Unsplash/CC0 Public DomainCanadian vaccination programs could switch to a 1-dose gender-neutral human papillomavirus (HPV) vaccination approach and

Updated on:November 11,2024 0

Do we need a new standard of care for colorectal cancer?

by University of VermontCredit: Pixabay/CC0 Public DomainIn recent years total neoadjuvant treatment (TNT)—a potent new treatment approach for advanced colorectal cancer that confronts tumors wit

Updated on: May 09,2024 3

Do we need a new standard of care for colorectal cancer?

by University of VermontCredit: Pixabay/CC0 Public DomainIn recent years total neoadjuvant treatment (TNT)—a potent new treatment approach for advanced colorectal cancer that confronts tumors wit

Updated on:May 09,2024 3

New insights into aggressive breast cancer and potential treatment options

by Marianne Lie Becker,University of Southern DenmarkThe findings made in the recent research projects. Credit: Professor Vijay Tiwari, University of Southern DenmarkTriple-negative breast cance

Updated on: April 06,2024 0

New insights into aggressive breast cancer and potential treatment options

by Marianne Lie Becker,University of Southern DenmarkThe findings made in the recent research projects. Credit: Professor Vijay Tiwari, University of Southern DenmarkTriple-negative breast cance

Updated on:April 06,2024 0